CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...